Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT)...

por He, Wenwu, Wang, Chenghao, Wu, Lei, Wan, Gang, Li, Baisen, Han, Yongtao, Li, Haojun, Leng, Xuefeng, Du, Kunyi, Chen, Haijun, Wang, Qifeng, Peng, Lin
Publicado 2022

Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis

por Li, Kexun, Du, Kunyi, Liu, Kun, Nie, Xin, Li, Changding, He, Wenwu, Li, Kunzhi, Wang, Chenghao, Li, Zhiyu, Zheng, Kai, Mao, Tianqin, Jiang, Longlin, Li, Haojun, Miao, Yan, Xie, Qin, Fang, Qiang, Han, Yongtao, Leng, Xuefeng, Peng, Lin
Publicado 2023

Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study

por Li, Kexun, Leng, Xuefeng, He, Wenwu, Du, Kunyi, Li, Changding, Liu, Kun, Wang, Chenghao, Liu, Guangyuan, Li, Zhiyu, Jiang, Longlin, Li, KunZhi, Zhou, Qiang, Li, Jialong, Luo, Xi, Nie, Xin, Lu, Simiao, Li, Haojun, Fang, Qiang, Xiao, Wenguang, Han, Yongtao, Peng, Lin
Publicado 2023